Our portfolio

InspectT

Enabling a new dimension in chemical analysis, InspectT develops and commercializes patented Optical-DOSY technology that adds size sensitivity to standard optical spectrometers, such as IR, UV/Vis, and Raman, without requiring instrument modification. This innovation fills a critical gap in R&D workflows across academia and industry, offering a cost-effective, non-invasive, and user-friendly alternative to traditional, often expensive and complex, size- and chemical-sensitive methods like NMR-DOSY or chromatography. The technology holds significant promise for accelerating innovation in pharmaceuticals, nanotechnology, and environmental reasearch.

Industry: Chemistry, Nanomaterials, Optics

Want to get in contact about InspectT?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Nasim Tavakoli

Physics, Quantum & Chemistry

Our portfolio

Check out similar ventures

Cellagenics

Scaling up therapeutic antibody production with STEP® technology.
Innovating stroke diagnosis with an AI-powered portable EEG for use inside the ambulance.
Developing a painless and more accurate mammography technology for breast cancer detection.
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.

Cellagenics

Scaling up therapeutic antibody production with STEP® technology.
Innovating stroke diagnosis with an AI-powered portable EEG for use inside the ambulance.
Developing a painless and more accurate mammography technology for breast cancer detection.
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.